AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011
Aug 8, 2011
33882_dirs_2011-08-08_3dfe6c64-f855-40aa-81a3-1943252703a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-08-05
Reporting Person: JACOBS CINDY (EVP, CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-05 | Common Stock | M | 10000 | $4.1051 | Acquired | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-08-05 | Stock Options | $4.1051 | M | 10000 | Disposed | 2012-09-12 | Common (10000) | Direct |
More from ACHIEVE LIFE SCIENCES, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30